Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NKTR
NKTR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NKTR News
Rezpegaldesleukin Shows Significant Efficacy at Dermatology Conference
2d ago
Newsfilter
Nektar Therapeutics Class Action Notice
4h ago
PRnewswire
Nektar Therapeutics Faces Class Action Lawsuit
21h ago
Globenewswire
Faruqi & Faruqi Encourages Nektar Investors to Reach Out
1d ago
PRnewswire
Reminder of Class Action Lawsuit for Nektar Therapeutics Investors
2d ago
Globenewswire
Rezpegaldesleukin Shows Significant Efficacy in Atopic Dermatitis and Alopecia Areata Studies
2d ago
Yahoo Finance
Rezpegaldesleukin Shows Significant Efficacy in Atopic Dermatitis and Alopecia Areata
2d ago
PRnewswire
Class Action Filed Against Nektar Therapeutics for Securities Violations
3d ago
Globenewswire
Nektar Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
3d ago
Globenewswire
Nektar Therapeutics Shareholder Class Action Notice
3d ago
Globenewswire
Multiple Companies Facing Class Action Lawsuits
4d ago
Globenewswire
Nektar Therapeutics Shareholder Claims Notification
4d ago
PRnewswire
Reminder of Class Action for Nektar Therapeutics Investors
5d ago
PRnewswire
Reminder of Class Action Lawsuit for Nektar Therapeutics Investors
5d ago
Globenewswire
Faruqi & Faruqi Investigates Nektar Securities Fraud Claims
5d ago
Globenewswire
Nektar Therapeutics Faces Class Action Lawsuit
6d ago
Globenewswire
Show More News
